Antibody Drug Conjugates
Antibody Drug Conjugates (ADCs) are therapeutic entities with monoclonal antibody (mAb) backbone linked to cytotoxic drugs and are designed to...
Antibody Drug Conjugate
Clinical Stage Antibody Drug Conjugates in Active Development – 2021
109 Antibody Drug Conjugates Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
Pre-Clinical Stage Antibody Drug Conjugates in Active Development – 2021
90 Antibody Drug Conjugates Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
Approved Monoclonal Antibodies for Cancer Treatment
In 1986, muromonab-CD3 (OKT3) wins the first therapeutic monoclonal antibody approval from the US FDA, which works as an immunosuppressive...